Evidence map›Paper›PMID 21970469›Full record

Trial reportTrials2011

Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial.

Thomas D Pinkney, David C Bartlett, William Hawkins, Tony Mak, Haney Youssef, Kaori Futaba, Gareth Harrison, Adrian Gheorghe, Jennifer M Bradbury, Melanie J Calvert and 7 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Review
  5. Response: don't give up on wound protectors yet.Langenbeck's archives of surgery · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Thomas D PinkneySurgical Registrar, West Midlands Deanery/West Midlands Research Collaborative, UK.
David C Bartlett
William Hawkins
Tony Mak
Haney Youssef
Kaori Futaba
Gareth Harrison
Adrian Gheorghe
Jennifer M Bradbury
Melanie J Calvert
George Dowswell
Laura Magill
Val Redman
Sue Wilson
David Leaper
Dion G Morton
West Midlands Research Collaborative
West Midlands Deanery · GBUniversity of Birmingham · GBCancer Research UK Clinical Trials Unit · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GBImperial College London · GB

Funding

Department of Health PB-PG-1208-18234
6 · The paper itself

Abstract

backgroundSurgical site infection (SSI) is a common complication following abdominal surgery. It is associated with considerable morbidity and mortality, and its management results in significant cost to health services within both primary and secondary care. Some surgeons believe that the use of a wound-edge protection device may reduce the incidence of SSI. Whilst there is some encouraging evidence showing that such devices may lead to a reduction in SSI, there are no controlled trials of sufficient size or quality to support their routine use. METHODS/

design750 patients will be recruited from around 20 surgical units within the United Kingdom. Patients undergoing laparotomy through any major abdominal incision for any indication, elective or emergency, are eligible. Patients under the age of 18, those undergoing a laparoscopic assisted procedure or who have undergone laparotomy within the previous 3 months, and those who are unable to give informed consent will be excluded. Patients will be randomised (1:1 ratio) to the use of a wound-edge protection device or no wound-edge protection device during surgery. Follow up will consist of blinded clinical wound reviews at 5-7 days and 30-33 days postoperatively with a self-completed questionnaire covering the intervening period. Quality of life questionnaires will be completed prior to surgery and at the subsequent wound review points and information on resource usage will also be captured.The primary outcome measure is SSI within 30 days of surgery. Secondary outcomes include the impact of the degree of wound contamination, patient comorbidity, and operative characteristics on the efficacy of a wound-edge protection device in reducing SSI and whether the use of a wound-edge protection device has an effect on health-related quality of life or length of hospital stay and is cost-effective. DISCUSSION: Rossini is the first multicentre observer-blinded randomised controlled trial of sufficient size and quality to establish whether the use of a wound-edge protection device in adult patients undergoing abdominal surgery leads to a lower rate of SSI. The results of this study will be used to inform current surgical practice and may potentially benefit patients undergoing surgery in the future. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN: ISRCTN40402832.

Indexed as

Clinical ProtocolsLaparotomyCost-Benefit AnalysisEquipment and SuppliesHumansOutcome Assessment, Health CareSurgical Wound Infection

Identifiers

PMID21970469
PMCPMC3201898
OpenAlexW2098579071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.